Skip to main content
. 2022 May 24;36(4):1312–1321. doi: 10.1111/jvim.16430

TABLE 3.

Selected clinicopathological baseline variables of initially normocalcemic cats that remain normocalcemic and those that develop persistent ionized hypercalcemia after diagnosis of azotemic chronic kidney disease.

Variables NCa‐NCa (n = 54) n NCa‐HCa (n = 25) n P
Median [25th, 75th percentile] Median [25th, 75th percentile]
Ionized calcium (mmol/L) 1.31 [1.28, 1.33] 54 1.32 [1.27, 1.35] 25 .29
Age (years) 15.4 [13.8, 16.7] 53 14.3 [11.3, 17.2] 24 .31
Albumin (g/dL) 3.1 [2.9, 3.3] 54 3.1 [2.9, 3.3] 25 .59
ALP (U/L) 30 [24, 40] 54 27 [22, 39] 25 .63
BCS (1‐9) 4 [3, 5] 54 5 [3, 6] 25 .17
Chloride (mEq/L) 119 [116, 120] 54 117 [115, 119] 25 .22
Creatinine (mg/dL) 2.38 [2.10, 2.89] 54 2.30 [2.05, 2.62] 25 .32
FGF23 (pg/mL) 523 [317, 874] 49 322 [218, 812] 25 .38
Globulin (g/dL) 4.6 [4.3, 5.2] 54 4.5 [4.2, 4.7] 25 .12
HCO3 (mEq/L) 20 [18, 23] 53 20 [19, 22] 25 .65
MMS (0‐2) 1 [1, 1] 52 1 [1, 1] 25 .64
PCV (%) 35 [30, 36] 54 35 [32, 42] 25 .031
Venous pH 7.35 [7.30, 7.38] 54 7.35 [7.31, 7.38] 24 .48
Phosphate (mg/dL) 3.92 [3.51, 4.76] 54 3.53 [3.09, 4.49] 25 .09
Potassium (mEq/L) 3.9 [3.6, 4.2] 54 4.0 [3.5, 4.3] 25 .84
PTH (pg/mL) 20.6 [13.6, 39.7] 54 11.4 [7.9, 34.0] 22 .10
SBP (mmHg) 133 [118, 142] 54 132 [119, 147] 24 .69
Sex (n [%] male) 22 (41) 54 10 (40) 25 1
Sodium (mEq/L) 153 [151, 155] 54 152 [149, 154] 25 .35
Total calcium (mg/dL) 9.9 [9.4, 10.2] 54 10.0 [9.8, 10.4] 25 .08
Total protein (g/dL) 7.7 [7.4, 8.2] 54 7.5 [7.2, 7.9] 25 .11
Weight (kg) 3.58 [3.06, 4.25] 52 4.04 [3.06, 4.72] 25 .25

Abbreviations: ALP, alkaline phosphatase; BCS, body condition score; FGF23, fibroblast growth factor 23; MMS, muscle mass score; PTH, parathyroid hormone; SBP, systolic blood pressure; USG, urine specific gravity.